Sramana Mitra: At this point, you had a bunch of customers. You had validation. Did your venture fund write you a check? Joe Kinsella: They did not. Along the way, I had a series of advisors. I had six advisors. The goal there was to really find people who complemented my skills. I had just
Entrepreneurs are invited to the 312th FREE online 1M/1M roundtable mentoring session on Thursday, July 7, 2016, at 8 a.m. PDT/11 a.m. EDT/8:30 p.m. India IST. If you are a serious entrepreneur, register to “pitch” and sell your business idea to Sramana Mitra. You’ll gain straightforward feedback, advice on next steps, and she’ll answer any
If you haven’t already, please study our Bootstrapping Course and Investor Introductions page. The morning that Brexit sent shockwaves through the world economy, I spoke with Demitris Memos who is building a nicely scaling, bootstrapped SaaS company from Athens, Greece. It was thrilling to hear a story of success and hope against the larger backdrop of doom and gloom. Greece
Sramana Mitra: Can you backtrack for me for a second and answer a couple of questions before we get to this point? I have a bit of a gap in the process here. You said you were running a bunch of experiments and one of them turned into this situation. How many such experiments around
Sramana Mitra: What about funding? Peter Gassner: We had funding from angel investors. We started off with $3 million. Then we said, “This is good, but we need some funding from outside. We were looking for validation and professional funding, and the things that a VC could bring.” We raised $4 million. We thought we
Happy Independence Day to our readers! This TechCrunch feature looks at apps that help you plan your vacations. For this week’s posts, click on the paragraph links.
Sramana Mitra: What year are we now? Joe Kinsella: 2012. Sramana Mitra: What was the relationship with Northbridge? Is that the company that had funded the company that you went to work for? Joe Kinsella: Yes, Northbridge was one of the investors in Silverback. One of the partners there, Jeff McCarthy, was on the Board
Peter Gassner: The thing that most people thought why it wouldn’t be good was that they’d say, “Hey, there are no big companies doing pharmaceutical CRM. Therefore, it’s not possible to build a big company doing it. What do you mean you will build your product on somebody else’s platform? Nobody had done that before.